Dana-Farber is thrilled to be honored by the Oncology Nursing Society with the 2023 Employer of the Year Award
Dana-Farber nurse scientists and clinicians presented key studies and projects at the 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, TX.
The ONS Congress is the largest, most comprehensive oncology nursing conference in the country, featuring nurse-led presentations that highlight the intersection of clinical knowledge, research, direct patient care, and advocacy resulting in innovation.
At this year’s Congress, Dana-Farber was recognized with the Outstanding Employer Award acknowledging employers who honor and show exemplary support for their oncology nurses.
“Dana-Farber is thrilled to be honored by the Oncology Nursing Society with the 2023 Employer of the Year Award,” says Senior Vice President for Patient Care Services and Chief Nursing Officer Anne Gross, PhD, RN, FAAN. “We are so proud of our clinical nurses and nurse scientists who are leading the field with their research and evidence-based practice efforts.”
Notable presentations by Dana-Farber nurses and researchers
✨ Utilization of an escape room to enhance new hire infusion nurse orientation
Dana-Farber’s Lauren Mcgovern, RN, presented the outcomes of the implementation of an escape room as part of orientation for newly hired oncology nurses.
✨Development of a tool to assess for ifosfamide induced neurotoxicity
Paula Aguilera, BSN, RN, presented research by a multidisciplinary team at Dana-Farber using high dose ifosfamide to treat patients with sarcoma. The team developed a systematic tool to detect the early signs of neurotoxicity associated with the treatment. This first-in-use tool identified early onset neurological changes.
✨Centering the Voices of African American Parents: Perspectives on psychosocial needs and support systems during childhood cancer
This study, presented by Ijeoma Julie Eche-Ugwu PhD, MPH, FNP-BC, AOCNP, CPHON, BMTCN, sought to elicit perspectives related to the psychosocial needs of African American parents of children with cancer.
✨The effect of infusion rate titration on taxane-related hypersensitivity: An evidence-based practice project
Presented by Terri Jabaley, PhD, RN, this evidence-based practice project at Dana-Farber found a three-step gradual rate titration of these medications during the first and second lifetime exposures decreased the rate of reactions by almost three-fold when compared to non-titrated doses.
Dana-Farber’s Rachel Pozzar, PhD, RN, FNP-BC, a nurse scientist in the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services and an instructor in medicine at Harvard Medical School, was awarded the 2023 Victoria Mock New Investigator Award and gave the Victoria Mock New Investigator lecture at the Congress.
Tamryn Gray, PhD, RN, MPH, a nurse scientist in the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber, delivered a lecture on The Dimensions of Caregiving: Emotional, Physical, and Financial Considerations of a Cancer Diagnosis.